• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Quantum Cyber Announces Plans to Establish U.S.-Based Defense-Technology Manufacturing Complex to Support Drone and Autonomous Systems Delivery

    5/28/26 7:00:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $QUCY alert in real time by email

    WEST PALM BEACH, Florida, May 28, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company, today announced a strategic initiative to establish a U.S.-based defense-technology manufacturing complex intended to support the production and delivery of autonomous drone and defense systems to end customers across federal government, Homeland Security, local government, and commercial sectors.

    Illustrations shown are conceptual and provided for marketing and visualization purposes only. Certain depicted systems, capabilities, payloads, specifications, and operational use cases may be under development, subject to change, or not currently commercially available.

    Illustrations shown are conceptual and provided for marketing and visualization purposes only. Certain depicted systems, capabilities, payloads, specifications, and operational use cases may be under development, subject to change, or not currently commercially available.

    The initiative reflects Quantum Cyber's planned transition from a technology development and licensing company to a vertically integrated defense platform with the goal of manufacturing and delivering combat-ready autonomous systems at scale. The planned facility is designed to support the Company's growing technology portfolio, which spans FPV drones, interceptor systems, counter-UAS platforms, autonomous ground vehicles, tethered surveillance systems, and naval mine countermeasure technologies.

    The Company's initial product line, developed through its technology licensing and acquisition program, includes the an advanced multi-platform unmanned aerial system with a range exceeding 25 kilometers, payload capacity of up to 3.0 kilograms, and autonomous takeoff, landing, and waypoint navigation with encrypted communications, designed for tactical operations, interception, and precision strike missions; a counter-UAS platform capable of speeds up to 350 kilometers per hour with operator-controlled terminal homing guidance, deployable from the ground or air-launched from a carrier drone; a lightweight tactical drone optimized for surveillance and precision engagement of ground targets; a Small Interceptor capable of speeds up to 220 kilometers per hour for rapid aerial neutralization; a Small Missile Launcher, a compact modular launcher supporting up to 8 missiles per platform with proximity sensor and remote detonation capability, effective at ranges up to 200 meters; and the Sky-Eye Aerial Repeater, a lightweight airborne signal relay system providing video and control transmission coverage up to 15 kilometers in complex and contested environments. The manufacturing complex is designed to bring in-house production capability across this entire product line and future additions to the Company's portfolio.

    "This is a pivotal step in our evolution," said David Lazar, Chief Executive Officer of Quantum Cyber. "We are not just acquiring and licensing technologies -- we are aiming to build the infrastructure to manufacture and deliver them. The forecasted demand from federal agencies, Homeland Security customers, and defense primes is real and it is growing. We intend to be ready to meet it."

    The planned complex is expected to include dedicated drone assembly workshops, a PCB and electronics production line, a CNC and 3D printing workshop for rapid component fabrication, quality assurance and calibration facilities, and supporting cybersecurity and server infrastructure. The facility is designed to enable the Company to produce multiple categories of autonomous systems simultaneously, with capacity spanning drone, ground vehicle, and autonomous marine platforms.

    The Company intends to provide further details on facility location, timeline, and production capacity as the initiative advances.

    About Quantum Cyber N.V.

    Quantum Cyber N.V. (NASDAQ:QUCY) is assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform that integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications under a single Nasdaq-listed company. The Company acquires, licenses, and develops combat-proven autonomous technologies, deploying them as a coordinated, multi-domain portfolio across air, land, and sea. For more information, visit www.quantum-cyber.ai.

    Forward-Looking Statements

    Certain statements made in this press release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from the Company's expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the failure to meet projected development and related targets; (ii) changes in applicable laws or regulations; (iii) an inability to successfully pursue new initiatives; and (iv) other risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the "SEC") by the Company. The Company's SEC filings are available publicly on the SEC's website at www.sec.gov. Any forward-looking statement made by the Company in this press release is based only on information currently available and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.

    Investor Relations Contact:

    Arx Investor Relations

    North American Equities Desk

    qucy@arxhq.com



    Primary Logo

    Get the next $QUCY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QUCY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $QUCY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Drones-as-a-Service Market Surges as AI, Automation, and Industrial Demand Drive Billion-Dollar Growth

    Market forecasts point to multi-billion-dollar expansion as businesses increasingly adopt outsourced drone operations to reduce costs and improve efficiencyNEW YORK, June 3, 2026 /CNW/ -- Market News Updates News Commentary - The concept of Drones as a Service (DaaS) is rapidly gaining momentum within the broader AI, automation, and industrial technology sectors. This trend is driven by businesses seeking cost-effective solutions for drone operations without the need to internally manage fleets. Instead of investing heavily in various aspects like hardware, software, pilots, compliance, and maintenance, companies are turning to subscription and on-demand service models to outsource their dro

    6/3/26 9:20:00 AM ET
    $ONDS
    $QUCY
    $UAVS
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Publishes Inaugural Corporate Investor Presentation Showcasing System-of-Systems Autonomous Defense Platform, Eight Filed Patent Positions, LOIs With General Cherry and SOCOM, and $15 Million Debt-Free Balance Sheet

    WEST PALM BEACH, Florida, June 03, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today published its inaugural Corporate Investor Presentation. The full presentation is available at https://quantum-cyber.ai/investors/presentations. The 19-slide deck consolidates the Company's previously announced milestones, technology portfolio, and strategic positioning into a single investor-facing document. Key sections include: Battle-Validated Autonomy and the QC-Core Platform. Ukra

    6/3/26 8:13:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Assumes Direct Manufacturing of Autonomous Drone; Expands BP United Agreement

    WEST PALM BEACH, Florida, June 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced an expansion of its existing relationship with BP United Inc. ("BP United"), the developer of autonomous unmanned vehicle systems that form the foundation of the Company's autonomous drone platform. Quantum Cyber Assumes Direct Manufacturing ControlThe Company and BP United have executed a First Amendment to the Intellectual Property License Agreement dated May 12, 2026 (the "A

    6/2/26 7:30:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $QUCY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ben-Tzvi Avraham was granted 137,141 units of Ordinary Shares, increasing direct ownership by 6,857% to 139,141 units (SEC Form 4)

    4 - Quantum Cyber N.V. (0001874252) (Issuer)

    5/26/26 6:12:13 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider O'Rourke Peter claimed no ownership of stock in the company (SEC Form 3)

    3 - Quantum Cyber N.V. (0001874252) (Issuer)

    5/21/26 7:07:23 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Natan David was granted 137,141 units of Ordinary Shares (SEC Form 4)

    4 - Quantum Cyber N.V. (0001874252) (Issuer)

    5/21/26 7:07:00 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $QUCY
    SEC Filings

    View All

    Mainz Biomed N.V. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Quantum Cyber N.V. (0001874252) (Filer)

    6/3/26 8:44:08 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Mainz Biomed N.V.

    DEF 14A - Quantum Cyber N.V. (0001874252) (Filer)

    6/1/26 5:19:22 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mainz Biomed N.V. filed SEC Form 8-K: Other Events

    8-K - Quantum Cyber N.V. (0001874252) (Filer)

    5/28/26 4:05:36 PM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $QUCY
    Financials

    Live finance-specific insights

    View All

    Quantum Cyber Publishes Inaugural Corporate Investor Presentation Showcasing System-of-Systems Autonomous Defense Platform, Eight Filed Patent Positions, LOIs With General Cherry and SOCOM, and $15 Million Debt-Free Balance Sheet

    WEST PALM BEACH, Florida, June 03, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today published its inaugural Corporate Investor Presentation. The full presentation is available at https://quantum-cyber.ai/investors/presentations. The 19-slide deck consolidates the Company's previously announced milestones, technology portfolio, and strategic positioning into a single investor-facing document. Key sections include: Battle-Validated Autonomy and the QC-Core Platform. Ukra

    6/3/26 8:13:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Assumes Direct Manufacturing of Autonomous Drone; Expands BP United Agreement

    WEST PALM BEACH, Florida, June 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced an expansion of its existing relationship with BP United Inc. ("BP United"), the developer of autonomous unmanned vehicle systems that form the foundation of the Company's autonomous drone platform. Quantum Cyber Assumes Direct Manufacturing ControlThe Company and BP United have executed a First Amendment to the Intellectual Property License Agreement dated May 12, 2026 (the "A

    6/2/26 7:30:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Cyber Announces Plans to Establish U.S.-Based Defense-Technology Manufacturing Complex to Support Drone and Autonomous Systems Delivery

    WEST PALM BEACH, Florida, May 28, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company, today announced a strategic initiative to establish a U.S.-based defense-technology manufacturing complex intended to support the production and delivery of autonomous drone and defense systems to end customers across federal government, Homeland Security, local government, and commercial sectors. Illustrations shown are conceptual and provided for marketing and visualization purposes only. Certain depicted systems, capabilities, payloads, specifications, and operational use cases may be under development, subject to change, or not currently

    5/28/26 7:00:00 AM ET
    $QUCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $QUCY
    Leadership Updates

    Live Leadership Updates

    View All

    Former Trump Administration VA Secretary Peter O'Rourke Sr. Joins Quantum Cyber's Board of Directors

    WEST PALM BEACH, Fla, May 14, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a company assembling an AI-powered System-of-Systems autonomous defense platform spanning drone warfare, counter-UAS, demining, and command-and-control applications, today announced the appointment of Peter M. O'Rourke Sr. as an independent member of its Board of Directors, effective immediately. Mr. O'Rourke served as Acting Secretary of the U.S. Department of Veterans Affairs (VA) under the Trump administration in 2018, where he led over 380,000 employees and helped oversee one of the largest federal healthcare and benefits systems in the country, with an annual bu

    5/14/26 8:01:00 AM ET
    $NVAC
    $PFSA
    $QUCY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations